Skip to content

Advancing Your Preclinical Insights through Robust Models Utilization to Accelerate IO Development & Clinical Confidence

 

The 4th Annual PREDiCT: Tumor Models San Francisco Summit 2020 will continue to serve immuno-oncology scientific community, helping them to gain a better understanding of candidate and preclinical profiling through robust selection of models and use of cutting-edge technologies. Explore the opportunities and limitations of syngenic and PDX mouse models, the potential of 3D models and gain a comprehensive understanding of novel technologies and imaging techniques that are changing the preclinical and translational field

This is your ONLY dedicated preclinical model summit that focuses on practical case studies and open collaboration, providing you with unparalleled takeaways to accelerate your drug development program.

Make these 3 days the best days in your 2020 calendar – engage with your industry fellow members, exchange learnings and be inspired for a fruitful 2020 program.

Take a look at the Full Event Guide here.

"This was a great conference for staying on top of some of the latest developments in IO models and getting a better understanding of the various models, their utility and limitations. The size of the conference allows for many fruitful discussions and ease of meeting with several of the major CROs that provide models for those in the immuno-oncology space."

Michael Mattie, Associate Director, Translational Medicine, Kite Pharma

Expert Speakers at the 4th Annual PREDiCT: Tumor Models San Francisco

Our Trusted Partners:

Lead Partner:

Jackson-Laboratory
Crown
Champions_Logo_Final
Covance
Hera-BioLabs-resize
Pharmatest-logo-2015
Proqinase + RBC (1)
studylog_logo-tag-cropped
RE_LOGO_CMYK-2
TriFoil

Official 2020 Media Partners:

CLSA_LOGO_RGB
Print
voicelogo
Pharmaceutical-logo